Lipoprotein lipase deficiency

Lipoprotein lipase deficiency (LPLD) is a rare genetic disorder characterized by the body's inability to break down lipids, specifically triglycerides, in the blood. This condition is caused by mutations in the LPL gene, which encodes the enzyme lipoprotein lipase.

Pathophysiology

Lipoprotein lipase is an enzyme crucial for the hydrolysis of triglycerides in chylomicrons and very low-density lipoproteins (VLDL) into free fatty acids and glycerol. These products are then taken up by tissues for energy production or storage. In individuals with LPLD, mutations in the LPL gene lead to a deficiency or complete absence of functional lipoprotein lipase, resulting in the accumulation of triglyceride-rich lipoproteins in the blood.

Symptoms

The symptoms of LPLD typically present in childhood and can include:

• Severe hypertriglyceridemia
• Recurrent episodes of pancreatitis
• Abdominal pain
• Hepatosplenomegaly
• Xanthomas
• Lipemia retinalis

Diagnosis

Diagnosis of LPLD is based on clinical presentation, family history, and laboratory tests. Key diagnostic criteria include:

• Elevated plasma triglyceride levels
• Presence of chylomicrons in fasting plasma
• Genetic testing confirming mutations in the LPL gene

Treatment

There is no cure for LPLD, but management focuses on reducing triglyceride levels to prevent complications. Treatment strategies include:

• A very low-fat diet
• Medium-chain triglycerides (MCTs) supplementation
• Avoidance of alcohol and simple sugars
• Use of fibrates and omega-3 fatty acids

Prognosis

With proper management, individuals with LPLD can lead relatively normal lives, although they must adhere to strict dietary restrictions to prevent complications such as pancreatitis.

See also

• Hyperlipidemia
• Genetic disorders
• Pancreatitis
• Triglycerides

External links

-